A Deep Dive into the Biden Administration’s COVID-19 Pandemic Response: Accountability and Reforms in the Administrative State

The House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust is set to hold a hearing on Wednesday, June 26, 2024, at 10:00 a.m. ET. The hearing, titled “Follow the Science?: Oversight of the Biden Covid-19 Administrative State Response,” will focus on the Subcommittee’s investigation into the Biden Administration’s actions in pressuring the Food and Drug Administration (FDA) to expedite the approval of the Pfizer COVID-19 vaccine and boosters by lowering agency standards.

The subcommittee will examine whether there is a need for reforms in the administrative state to ensure accountability within agencies, especially in vaccine approval processes. The witnesses scheduled to testify at this hearing include Dr. Philip Krause, a former Deputy Director of the FDA Office of Vaccines Research & Review, Aaron Siri, a vaccine litigation expert, Dr. Jordan Vaughn of Birmingham, Founder and President of the Microvascular Research Foundation, and Dr. Andrew Tobias Pavia of the University of Utah School of Medicine among others who will provide testimony based on their expertise and experiences related to oversight during COVID-19 pandemic response by Biden administration.

The approval of the vaccine allowed for its mandate use despite concerns about potential injuries among young healthy Americans. This raises questions about how accountable regulatory agencies are when it comes to drug safety regulations.

Overall this hearing aims to shed light on how regulatory oversight can be improved upon in order to prevent similar issues from happening again in future crisis situations like COVID-19 pandemic response.